Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It acts as a positive allosteric modulator of the GABA-A receptor, enhancing inhibitory neurotransmission.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus (treatment of active seizure)
* Preoperative sedation and anxiolysis
* Management of alcohol withdrawal symptoms
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally, three times daily. Maximum: 10 mg/day.
* **Insomnia:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously. May repeat in 5-10 minutes if seizures persist. Maximum: 8 mg in a 24-hour period (though higher doses may be used under medical supervision).
* **Preoperative:** 2 mg to 4 mg intramuscularly or intravenously 2 hours before surgery.
* **Alcohol Withdrawal:** 1 mg to 4 mg orally or intravenously every 4-6 hours as needed. Dosing is highly individualized and dependent on severity.
## Pediatric Dosing
Dosing in children is less established and should be guided by expert clinical judgment and institutional protocols.
* **Status Epilepticus:** 0.05 mg/kg intravenously, not to exceed 4 mg/dose, given slowly over 2-5 minutes. May be repeated once after 10-15 minutes if seizures recur.
* *Other indications (e.g., anxiety) are generally not recommended in pediatrics due to limited data and potential for adverse effects.*
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is typically recommended, but monitor for increased sensitivity.
* **Elderly:** Initiate at lower doses (e.g., 0.5 mg twice daily) and titrate cautiously due to increased sensitivity to CNS effects.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, fatigue, sedation, ataxia, confusion.
Less Common: Hypotension, respiratory depression (especially with IV administration or in combination with other CNS depressants), paradoxical excitation, anterograde amnesia, dependence, withdrawal symptoms.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, antihistamines, other sedatives):** Additive CNS depression, increasing risk of sedation, respiratory depression, coma, and death.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, a pathway less affected by CYP450 enzymes, so significant drug interactions via this route are less common compared to other benzodiazepines. However, caution is still advised.
## Monitoring
* Level of consciousness and sedation.
* Respiratory rate and oxygen saturation (especially with IV administration).
* Vital signs.
* Signs of withdrawal if patient is dependent.
* For seizure control, monitor seizure frequency and duration.
## Clinical Pearls
* Lorazepam has a relatively short half-life, which can be advantageous for managing acute symptoms but may lead to more frequent dosing or withdrawal symptoms with prolonged use.
* Intravenous administration should be slow to minimize respiratory depression and hypotension.
* Avoid abrupt discontinuation after prolonged use; taper dose gradually to prevent withdrawal.
* Pregnancy category D. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
* Can be administered orally, intramuscularly, or intravenously. Intramuscular absorption can be erratic.
***
*This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before administering any medication. Dosing may vary based on institutional protocols and individual patient factors.*
